Back to the Front Page


 
Success Stories  


Prescient Therapeutics Ltd. (ASX:PTX) (Formerly Virax Holdings Limited)

Immuno-therapeutics
Virax Holdings Limited was a publicly listed early-stage development biopharmaceutical company focused on the development of immuno- therapeutics for the treatment of autoimmune disorders, HIV/AIDS, cancers and infectious diseases. TSL was employed by Virax as its corporate advisor to conduct several capital raisings.

TSL's Role:

  • Conducted a public capital raising of $2.8 million in late 1998
  • Conducted a private placement of $4.19 million in July 2000
  • Provided corporate advisory services, including assistance with prospectus preparation and related offer documentation, planning and coordination of road-show presentations to brokers and investors, and advice on issue price and timing

To learn more about Prescient Therapeutics Limited visit their web-site here.